Although IFN responses are the original mechanism to fight against EBV infection, consistent IFN responses after the malignant transformation of epithelial cells can result in shaping TME into a more tolerant state, promoting tumoral signal, facilitating tumor cell survival, and leading to adverse outcomes (51). The gene discussed is IFNA1; the disease is Epstein-Barr virus infection.